2024 ´ëÇѺÎÀÎÁ¾¾çÇÐȸ Á¦39Â÷ Ãá°èÇмú´ëȸ 2ÀÏÂ÷ : 2024-04-27 |
|
2024 ´ëÇѺÎÀÎÁ¾¾çÇÐȸ Á¦39Â÷ Ãá°èÇмú´ëȸ 2ÀÏÂ÷ : 2024-04-27 ±³À°ÁÖÁ¦ : 2024 ´ëÇѺÎÀÎÁ¾¾çÇÐȸ Á¦39Â÷ Ãá°èÇмú´ëȸ 2ÀÏÂ÷ ÁÖÃÖ±â°ü : ´ëÇѺÎÀÎÁ¾¾çÇÐȸ À̸ÞÀÏ : gyncancer@gyncancer.or.kr ±³À°Á¾·ù : »êºÎÀΰú Âü¼®¿¹»óÀÎ : 350¸í Áö¿ª : ºÎ»ê±¤¿ª½Ã ¼¼ºÎ¼ö°·á : 150,000¿ø ºñ°í - ºÎÀÎ¾Ï ºÐ°úÀü¹®ÀÇ : 15¸¸ ¿ø- ÀüÀÓÀÇ ¹× ±âŸ ºÐ°ú Àü¹®ÀÇ : 13¸¸ ¿ø- Àü°øÀÇ : 10¸¸ ¿ø- ¿¬±¸¿ø ¹× °£È£»ç : 11¸¸ ¿ø- 65¼¼ ÀÌ»ó : ¹«·á((¸¸Âù 2¸¸¿ø Ãß°¡ / JGO Workshop : ¹«·á)
±³À°½Ã°£ 04¿ù 27ÀÏ 5A Hall 09:00~09:15 Update of hereditary gynecologic cancer guideline ÇÏÇüÀÎ(ºÎ»êÀÇ´ë) Åä·Ð 04¿ù 27ÀÏ 5A Hall 09:15~09:20 Floor discussion ( ) ±³À°½Ã°£ 04¿ù 27ÀÏ 5A Hall 09:20~09:35 Clinical application of BRCA/HRD in the management of ovarian cancer ¾î°æÁø(¿¬¼¼ÀÇ´ë) Åä·Ð 04¿ù 27ÀÏ 5A Hall 09:35~09:40 Floor discussion ( ) ±³À°½Ã°£ 04¿ù 27ÀÏ 5A Hall 09:40~09:55 Clinical application of MMR in the management of endometrial cancer ±èÁöÇö(±¹¸³¾Ï¼¾ÅÍ) Åä·Ð 04¿ù 27ÀÏ 5A Hall 09:55~10:00 Floor discussion ( ) ±³À°½Ã°£ 04¿ù 27ÀÏ 5A Hall 10:00~10:30 ÀÇÇÐ³í¹®¿¡¼ »ý¼ºÇü AIÀÇ È°¿ë »ç·Ê À¯½ÂÂù(¿¬¼¼ÀÇ´ë ÀÇ»ý¸í½Ã½ºÅÛÁ¤º¸Çб³½Ç) Åä·Ð 04¿ù 27ÀÏ 5A Hall 10:30~10:50 Q&A ( ) ÈÞ½Ä 04¿ù 27ÀÏ 11:00~11:20 Break Time ( ) ±³À°½Ã°£ 04¿ù 27ÀÏ 5A Hall 11:20~11:35 Advanced/recurrent cervical cancer ¾î°æÁø(¿¬¼¼ÀÇ´ë) Åä·Ð 04¿ù 27ÀÏ 5A Hall 11:35~11:40 Floor discussion ( ) ±³À°½Ã°£ 04¿ù 27ÀÏ 5A Hall 11:40~11:55 Advanced/recurrent endometrial cancer ³²¼ÒÇö(¿ï»êÀÇ´ë) Åä·Ð 04¿ù 27ÀÏ 5A Hall 11:55~12:00 Floor discussion ( ) ±³À°½Ã°£ 04¿ù 27ÀÏ 5A Hall 12:00~12:15 Major three A/E: management tips ÀÓÇöÁö(¼¿ïÀÇ´ë) Åä·Ð 04¿ù 27ÀÏ 5A Hall 12:15~12:20 Floor discussion ( ) ±³À°½Ã°£ 04¿ù 27ÀÏ 5A Hall 12:20~12:35 Beyond the immune-oncologics in gynecologic cancer ÀÌ¿ëÀç(¿¬¼¼ÀÇ´ë) Åä·Ð 04¿ù 27ÀÏ 5A Hall 12:35~12:40 Floor discussion ( ) ±³À°½Ã°£ 04¿ù 27ÀÏ 5A Hall 12:40~13:00 Pembrolizumab in combination with CCRT: the next frontier for LACC ½Å¼ÒÁø(°è¸íÀÇ´ë) ±³À°½Ã°£ 04¿ù 27ÀÏ 5A Hall 13:00~13:20 Clinical benefit of Niraparib as 1L maintenance in newly diagnosed ovarian cancer focused on BRCAmut and HRD ³ëÁØÈ£(¼¿ïÀÇ´ë) ÈÞ½Ä 04¿ù 27ÀÏ 13:20~13:50 Break Time ( ) ±³À°½Ã°£ 04¿ù 27ÀÏ 5A Hall 13:50~14:20 Experience of Operating the Molecular Tumor Board Jihong Liu(Sun Yat-sen University Cancer Center) Åä·Ð 04¿ù 27ÀÏ 5A Hall 14:20~14:30 Case presentation Ȳµ¿¿ø(ÀÎÁ¦ÀÇ´ë) Åä·Ð 04¿ù 27ÀÏ 5A Hall 14:30~14:40 Floor discussion ( ) ÈÞ½Ä 04¿ù 27ÀÏ 14:40~15:00 Break Time ( ) ±³À°½Ã°£ 04¿ù 27ÀÏ 5A Hall 15:00~15:20 Interpretation of Endometrial Curettage ±èÇö¼ö(¼º±Õ°üÀÇ´ë) Åä·Ð 04¿ù 27ÀÏ 5A Hall 15:20~15:25 Floor discussion ( ) ±³À°½Ã°£ 04¿ù 27ÀÏ 5A Hall 15:25~15:45 Practical Approach of Molecular Classification in Endometrial Cancer ±èÈ¿Áø(¼¿ïÀÇ´ë) Åä·Ð 04¿ù 27ÀÏ 5A Hall 15:45~15:50 Floor discussion ( ) ±³À°½Ã°£ 04¿ù 27ÀÏ 5A Hall 15:50~16:10 2023 Revised FIGO Stage of Endometrial Cacner ¹ÚÀºÇâ(¿¬¼¼ÀÇ´ë) Åä·Ð 04¿ù 27ÀÏ 5A Hall 16:10~16:15 Floor discussion ( ) ±³À°½Ã°£ 04¿ù 27ÀÏ 321/322/323/324 10:00~10:20 ±¹³»¿Ü ÀڱðæºÎ¾Ï °ËÁø ±Ç°í¾È ¼Ò°³ ÀÓö±Ç(À»ÁöÀÇ´ë) ±³À°½Ã°£ 04¿ù 27ÀÏ 321/322/323/324 10:20~10:40 ±¹³» HPV °Ë»ç ÇöȲ ¹× Á¤µµ °ü¸® ÇöȲ ±èÁÖÇö(¿ï»êÀÇ´ë) ±³À°½Ã°£ 04¿ù 27ÀÏ 321/322/323/324 10:40~11:00 HPV °Ë»ç ÀÓ»ó ±Ç°í¾È °èȹ ¹× ±¸¼º ¼Ò°³ ±è¼¼ÀÍ(¼¿ïÀÇ´ë) Åä·Ð 04¿ù 27ÀÏ 11:00~12:00 Floor discussion ( ) ±³À°½Ã°£ 04¿ù 27ÀÏ 13:20~13:50 Lunch Time ( ) ±³À°½Ã°£ 04¿ù 27ÀÏ 321/322/323/324 13:50~14:02 (ÃʷϹßÇ¥) Video demonstration of vNOTES pelvic lymphadenectomy in gynecologic cancer À̱ÙÈ£(°¡Å縯ÀÇ´ë) Åä·Ð 04¿ù 27ÀÏ 321/322/323/324 14:02~14:05 Floor discussion ( ) ±³À°½Ã°£ 04¿ù 27ÀÏ 321/322/323/324 14:05~14:12 (ÃʷϹßÇ¥) Metastatic pancreatic carcinoma to the uterine cervix, vNOTES contributed to the diagnosis.£ºA case report. Yu Kamishita(Saga-Ken Medical Centre Koseikan Japan) Åä·Ð 04¿ù 27ÀÏ 321/322/323/324 14:12~14:15 Floor discussion ( ) ±³À°½Ã°£ 04¿ù 27ÀÏ 321/322/323/324 14:15~14:22 (ÃʷϹßÇ¥) Robot assisted laparoscopic surgery in loco-regionally recurrent ovarian cancer ¼Û¹ÎÁ¾(°¡Å縯ÀÇ´ë) Åä·Ð 04¿ù 27ÀÏ 321/322/323/324 14:22~14:25 Floor discussion ( ) ±³À°½Ã°£ 04¿ù 27ÀÏ 321/322/323/324 14:25~14:32 (ÃʷϹßÇ¥) Ureteroureterostomy during laparoscopic radical hysterectomy ¹Úö¹Î(Á¦ÁÖÀÇ´ë) Åä·Ð 04¿ù 27ÀÏ 321/322/323/324 14:32~14:35 Floor discussion ( ) ±³À°½Ã°£ 04¿ù 27ÀÏ 121/122 09:00~09:30 ¼ö¼úµ¿ÀǼ ¼Ò°³ (¿ÜÀ½ºÎ¾Ï, ÀÚ±ÃÀýÁ¦¼ú) ÀÌ°Ç¿ì(Ãæ³²ÀÇ´ë) Åä·Ð 04¿ù 27ÀÏ 121/122 09:30~09:40 Distallate discussion ¿À¼öÇö(°¡ÃµÀÇ´ë) ÈÞ½Ä 04¿ù 27ÀÏ 09:40~10:00 Break Time ( ) ±³À°½Ã°£ 04¿ù 27ÀÏ 121/122 10:00~10:25 ÀڱðæºÎ¾Ï ÀÌÇØÇϱ⠹ڻóÀÏ(µ¿³²±Ç¿øÀÚ·ÂÀÇÇпø) ±³À°½Ã°£ 04¿ù 27ÀÏ 121/122 10:25~10:50 Àڱ󻸷¾Ï ÀÌÇØÇϱâ Áö¿ëÀÏ(ºÎ»êÀÇ´ë) ±³À°½Ã°£ 04¿ù 27ÀÏ 121/122 10:50~11:15 ³¼Ò¾Ï ÀÌÇØÇϱ⠼µ¿¼ö(°í½ÅÀÇ´ë) ±³À°½Ã°£ 04¿ù 27ÀÏ 121/122 11:15~11:40 ºÎÀξϿ¹¹æÇϱ⠺¯Á¤¹Ì(ÀÎÁ¦ÀÇ´ë) Åä·Ð 04¿ù 27ÀÏ 121/122 11:40~12:00 ÁúÀÇ ¹× Åä·Ð ( ) ÈÞ½Ä 04¿ù 27ÀÏ 12:00~13:50 Break Time ( )
|
Tip. ±³À°ÀÏÁ¤Àº ±³À°±â°üÀÇ »çÁ¤¿¡ µû¶ó º¯°æµÉ ¼ö ÀÖÀ¸¹Ç·Î »çÀü¿¡ ¹Ýµå½Ã ±³À°±â°üÀ¸·Î ¹®ÀÇÇÏ¿© È®ÀÎ ¹Ù¶ø´Ï´Ù. |
|
Á¦¸ñ |
Ãßõ¼ö : 0 , Á¶È¸¼ö : 894 , ´ñ±Û¼ö : 0 |
Ãßõ¼ö : 0 , Á¶È¸¼ö : 686 , ´ñ±Û¼ö : 0 |
Ãßõ¼ö : 0 , Á¶È¸¼ö : 656 , ´ñ±Û¼ö : 0 |
Ãßõ¼ö : 0 , Á¶È¸¼ö : 775 , ´ñ±Û¼ö : 0 |
Ãßõ¼ö : 0 , Á¶È¸¼ö : 822 , ´ñ±Û¼ö : 0 |